One of London’s largest public transport operators has selected the Intelligent Fingerprinting Drug Screening System to support its commitment to safety, efficiency, and modernization across its network.

The contract covers 14 operational sites across Greater London and a workforce of over 4,400 employees. The operator’s multi-garage bus network carries more than one million passengers each day, with a fleet of over 1,400 low-emission buses, including hybrid, electric, and hydrogen-powered vehicles.

Rapid, Scalable Testing for Safety-Critical Environments

Our fingerprint sweat-based drug testing technology enables quick and reliable workplace drug testing at scale, helping reduce downtime and keep operations running smoothly. For public transport providers, where service interruptions can have widespread impacts, minimising time away from duty is critical.

Harry Simeonidis, President and CEO, explained:

“We offer a system that supports rapid drug testing at scale, meaning less people out of action for less time. This minimises financial loss associated with long wait times and improves overall workforce efficiency. The rapidly rising popularity of our solution is testament to the many benefits it offers businesses of all sizes; from a greater suggestion of impairment and reduced risk to cost savings and a more dignified approach.”

A Modern Approach to Workforce Safety

The decision to implement our system is part of the operator’s broader investment in people, infrastructure, and safety. Backed by purpose-built engineering and logistics facilities, they represent a forward-thinking leader in the transport sector, embracing solutions that keep employees, passengers, and the public safe.

Growing Global Reach

Intelligent Fingerprinting’s technology is now used by more than 450 accounts in 24 countries, supported by 18 distribution partners. While we continue to expand across the UK, our presence is also growing in Europe, the Middle East and Africa, Asia Pacific, and the United States. Securing U.S. Food and Drug Administration (FDA) clearance remains a priority, with U.S. market entry planned for 2025.

Intelligent Fingerprinting is a wholly-owned subsidiary of Intelligent Bio Solutions.

The Intelligent Fingerprinting Drug Screening System is gaining traction across Sweden, Norway, and Denmark through a growing partnership with regional distributor Spjotgard. With increasing interest from Finland, the partnership reflects the growing demand for non-invasive, dignified alternatives to traditional drug testing methods. Founded in 2021 by a team with deep pharmaceutical expertise, Spjotgard has quickly become a trusted provider of workplace drug testing solutions in Scandinavia. The company has positioned the Intelligent Fingerprinting Drug Testing Solution as its flagship solution in response to shifting regional expectations for accuracy, hygiene, and user experience.

“From the very beginning, we’ve seen strong interest in fingerprint-based testing across the region,” said Hans Svensson, ­­joint owner of Spjotgard. “Traditional methods like saliva and urine are still common, but our customers, especially in workplace safety and education, are seeking more hygienic, easy to use and less invasive alternatives. Fingerprint drug testing delivers that while delivering comparable levels of accuracy, saving time and reducing disruption.”

Rising concerns about drug driving and youth substance misuse in Sweden are prompting organizations to adopt more proactive screening strategies. Fingerprint drug testing supports this shift by delivering results in under ten minutes, without the need for supervision or bathroom facilities. It is already in use across logistics, construction, warehousing, education, and the criminal justice sector.

Spjotgard continues to expand its reach by partnering with complementary service providers, including companies offering alcohol testing solutions and drug-detection dog services. This includes a partner with a long-standing presence in evidential alcohol testing instruments for judicial authorities and automated alcohol entry systems for workplaces.

“Scandinavia is setting a high standard in progressive drug testing policy, particularly Sweden, which is often seen as a model for neighboring countries,” said Doug Heath, Vice President of Global Sales at Intelligent Bio Solutions. “Spjotgard’s strong market knowledge and trusted relationships make them a valuable partner as we continue to scale across Northern Europe.”

The Intelligent Fingerprinting Drug Screening System allows for rapid, on-site drug screening using fingerprint sweat. Unlike traditional methods requiring supervision, third-party administration, or removing staff from the job, fingerprint drug testing offers a discreet and efficient solution that is quickly gaining favor among HR teams, health and safety managers, and union representatives in Scandinavia.

With more than 450 customer accounts in 24 countries, Intelligent Fingerprinting continues to support the global transition toward more effective and respectful workplace drug testing.

Intelligent Fingerprinting is a wholly-owned subsidiary of Intelligent Bio Solutions Inc.

The Intelligent Fingerprinting Drug Testing Solution is Being Showcased at the RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing

Intelligent Bio Solutions alongside it’s U.S. distribution partner SMARTOX will be participating at the All Rise Conference, RISE25, in Kissimmee, Florida from May 28 to 31, 2025, showcasing the unique Intelligent Fingerprinting Drug Testing Solution. The Solution is already used in the U.S. in a Forensic Use Only capacity through its partnership with SMARTOX.

Harry Simeonidis, President and CEO at Intelligent Bio Solutions, and Doug Heath, Vice President of Global Sales at Intelligent Bio Solutions, will join Duffy Nabors, Vice President of Sales and Marketing at SMARTOX, to demonstrate the Company’s portable, easy-to-use Intelligent Fingerprinting Drug Screening System. The System uses fingerprint sweat to detect recent drug use, including cannabis (THC), cocaine, methamphetamine, and opiates, and deliver results in under ten minutes. The hygienic and discreet collection method is well-suited to treatment court settings, probation programs, and other criminal justice applications where privacy, reliability, and speed are critical.

RISE25 is the leading U.S. conference on addiction, mental health, and justice innovation. Drawing over 7,000 attendees annually, it brings together treatment court professionals, judges, probation officers, therapists, attorneys, researchers, and policymakers. Since 1995, the event has served as a national platform for public health and justice professionals seeking evidence-based approaches for individuals impacted by substance use, co-occurring disorders, and trauma.

“The RISE conference represents a national effort to transform justice responses to substance use and mental health,” said Doug Heath, Vice President of Global Sales at Intelligent Bio Solutions. “We’re proud to support SMARTOX in showcasing our solution and to contribute to the conversation around dignity, access, and effective methods for forensic drug testing.”

Intelligent Bio Solutions’ presence at RISE25 marks its commitment to health and safety across all sectors and demonstrates its dedication to providing dignified, innovative solutions in global markets. As the Company pursues FDA approval of its Intelligent Fingerprinting Drug Screening System and advances plans to enter the U.S. market this year, the event provides a unique platform for Intelligent Bio Solutions to connect with key stakeholders, including potential customers, investors, and partners, who are interested in innovative solutions that promote health and safety. The Forensic Use Only market in the U.S. offers numerous avenues for expansion, and the Company believes its technology can provide substantial benefits in this area. With over 450 active accounts across 24 countries, the Company continues to meet growing global demand for reliable, on-site drug testing solutions across the workplace, treatment, and justice sectors.

About SMARTOX

SMARTOX, founded in 2012, is a U.S.-based provider of drug and alcohol testing products and services. It offers a comprehensive portfolio supporting a wide range of settings, including healthcare, justice, corporate, and education. SMARTOX is committed to delivering advanced technology and exceptional results, providing fully integrated services encompassing design, customer service, and administrative support for its product line.

Completion of 160 non-invasive drug tests in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approaches

The Intelligent Fingerprinting Drug Screening System was recently used to successfully complete a high-volume of workplace drug testing for Barcaldine Regional Council in remote Queensland, Australia. In less than 90 minutes, more than 160 employees, representing 100% of the workforce, were tested and cleared as fit for duty before the start of the workday using the non-invasive drug testing solution. The speed and efficiency of the operation ensured minimal disruption to business operations.

“The level of speed and efficiency we have shown here simply isn’t possible with traditional testing methods,” said Doug Heath, Global Vice President of Sales. “If the Council had relied on urine or saliva testing, the process would likely have disrupted operations for over a day. Traditional testing requires private facilities, supervised collection, and nil-by-mouth waiting periods for saliva testing. If urine testing, delays caused by ‘shy bladder’ procedures can extend the process by up to three hours per donor, requiring restricted water intake, constant monitoring, and multiple collection attempts to achieve a valid sample. With confirmation and chain-of-custody requirements, these methods could have extended testing across multiple shifts.”

The Intelligent Fingerprinting Drug Screening System allowed for delivery of a comprehensive on-site collect-and-test service, demonstrating capability to deliver testing anywhere, anytime, including in remote locations. The speed and non-invasive nature of the drug testing solution enabled testing to be completed before 8:00 a.m., well ahead of the full day allocated, allowing Council staff to resume work immediately. The Council expressed satisfaction with the confirmation rate of non-negative results, validating the System’s high level of accuracy.

“The testing process was handled professionally from start to finish,” said Adele Bintley, Manager of People, Culture and Organizational Performance at Barcaldine Regional Council. “We were impressed by how quickly testing was completed and how seamlessly the entire process was coordinated. It’s an excellent solution for remote councils like ours.”

Following the initial test, Council personnel were trained to conduct random testing in-house, with plans for complete workforce tests to continue through the Company’s on-site testing model. This deployment has opened a new market for the Company, showing that a fully managed, on-location service is viable and valuable in regional settings.

“The ability to test an entire workforce in such a short window and still achieve high levels of accuracy is a key benefit of our non-invasive drug testing system,” continued Doug Heath, Global Vice President of Sales. “It supports safer workplaces without compromising productivity, particularly in regional and remote areas where traditional methods can be logistically and operationally challenging.”

Arabic, Italian, and Spanish-language websites unlock access to fingerprint sweat-based testing in regions representing over 1.4 billion people

Intelligent Fingerprinting is a wholly-owned subsidiary of Intelligent Bio Solutions Inc.

Intelligent Fingerprinting has launched three new multilingual websites in Arabic, Italian, and Spanish. This rollout supports the Company’s global growth plans and international sales expansion by opening digital and commercial access to some of the world’s fastest-growing, high-demand regions for workplace safety and compliance solutions.

The new multilingual websites will broaden access to the Intelligent Fingerprinting Drug Testing Solution across Europe, the Middle East, and Latin America. Collectively, these regions represent a combined population of over 1.4 billion people[1].

“This is not just a translation project; it’s a commercial growth engine,” said Harry Simeonidis, President and CEO at Intelligent Bio Solutions. “By localizing our online presence and sales infrastructure to make it ready for use by customers across the globe, we are building scalable access to high-potential markets. These initiatives are the foundation for strengthening distributor relationships, increasing lead generation, and facilitating faster market penetration worldwide.”

The Company has already seen strong interest from international partners following recent advancements in multilingual reader functionality, which enables its fingerprint sweat-based drug screening system, a portable, hygienic, and dignified alternative to urine or saliva testing, to be accessible and deployable in non-English speaking environments.

With strong growth opportunities across Latin America, the Middle East, and Southern Europe. In Latin America, the drug screening market is projected to reach USD 1.1 billion by 2030[2], with Spanish serving as the official language in 20 countries across the region. Meanwhile, Gulf Cooperation Council (GCC) countries continue to strengthen enforcement of workplace safety standards, driving demand for compliant screening solutions in the Middle East.

The new websites are expected to strengthen inbound demand and accelerate conversion across distribution and sales channels by removing language barriers and aligning with regional expectations. They further complement the Company’s ongoing commercial initiatives, including expansion of its global distributor network and increased investment in digital lead generation and localization infrastructure.

The Intelligent Fingerprinting Drug Screening System is designed to detect recent drug use through fingerprint sweat analysis, providing results in under ten minutes. With over 400 active accounts in 19 countries, the Company continues to lead the evolution of drug screening technology, serving industries including construction, manufacturing, transport, and logistics.

Interested in Partnering with Us?

We are looking for partners to expand our presence and distribute our innovative drug screening solution globally. The Intelligent Fingerprinting Drug Screening System is designed to detect recent drug use through fingerprint sweat analysis, providing results in under ten minutes. With over 400 active accounts in 19 countries, the Company continues to lead the evolution of drug screening technology, serving industries including construction, manufacturing, transport, and logistics. Click here to become a drug testing distributor.

References

[1] United Nations, 2024. World Population Prospects 2024, Department of Economic and Social Affairs, Population Division. Available at: https://population.un.org/wpp/

[2] Grand View Research 2025. Latin America Drug Screening Market Size & Outlook. Available at: https://www.grandviewresearch.com/horizon/outlook/drug-screening-market/latin-america

Intelligent Fingerprinting is a wholly-owned subsidiary of Intelligent Bio Solutions Inc.

The Intelligent Fingerprinting Drug Screening System has been upgraded to meet the growing demand in Latin American-Spanish-speaking markets. The enhancement allows users to operate the System in English, Arabic, and Latin American Spanish, extending the platform’s usability across diverse international settings.

Spanish is the fourth most spoken language in the world and the second most spoken language in the U.S. It is the official language in over 20 countries, including the majority of countries in Latin America, and is spoken by over 500 million people globally[1]. By incorporating Latin American Spanish into the System, INBS strengthens its support for Spanish-speaking markets and regional distribution partners. This update increases accessibility for end-users across North America, Central America, South America, and Europe, aligning with the Company’s strategic growth plans.

“As we see increased interest from Spanish-speaking distributors and companies, we must ensure our solution remains accessible and relevant to these markets. Integrating Latin American Spanish into our System is a key step toward opening new opportunities for future growth,” said Harry Simeonidis, President & CEO at Intelligent Bio Solutions. “As demand grows, so does the value of business localization. Our product stands out in the market by offering local language capabilities, something most solutions don’t provide. It’s a clear differentiator.”

The Latin American drug screening market is projected to reach USD 1.1 billion by 2030, driven by increasing public safety initiatives and growing demand for workplace compliance programs[2]. In Europe, Spain’s drug testing market is expected to reach USD 368.4 million by 2030[3], reflecting similar trends in regulation and adoption. The System’s multilingual capabilities position the Company to better serve evolving testing needs through an intuitive, localized platform experience.

This development forms part of the Company’s major multilingual system upgrade announced earlier this year. The complete multilingual upgrade will support multiple languages spoken across the Americas, Europe, Asia Pacific, and the Middle East, making the System accessible to over four billion speakers worldwide[4]. The added capability supports a broader growth strategy to expand on a foundation of over 400 accounts across 19 countries and to penetrate new markets and regions. The Latin American Spanish enhancement is a key development milestone as the Company prepares to enter the multi-billion-dollar U.S. market this year, following its FDA 510(k) submission in December 2024.

References

[1] Statista 2025. Countries with the largest number of native Spanish speakers worldwide in 2024. Available at: https://www.statista.com/statistics/991020/number-native-spanish-speakers-country-worldwide/ 

[2] Grand View Research 2025. Latin America Drug Screening Market Size & Outlook. Available at: https://www.grandviewresearch.com/horizon/outlook/drug-screening-market/latin-america

[3] Grand View Research 2025. Spain Drug Screening Market Size & Outlook, 2018-2030. Available at: https://www.grandviewresearch.com/horizon/outlook/drug-screening-market/spain

[4] Ethnologue, 2024. The Ethnologue 200. Available at: https://www.ethnologue.com/insights/ethnologue200/

Intelligent Fingerprinting is a wholly-owned subsidiary of Intelligent Bio Solutions Inc.

Arabic is the second international language integrated into the Intelligent Fingerprinting Drug Screening System as part of the Company’s multilingual upgrade.

Arabic is spoken by approximately 450 million people worldwide, holding official status in nearly 25 countries[1]. With this update, fingerprint drug testing technology will be made more accessible to Arabic-speaking organizations in safety-critical industries, law enforcement and drug rehabilitation.

Integrating the Arabic language into the Intelligent Fingerprinting Drug Screening Reader will improve accessibility and usability for Arabic-speaking organizations in the Middle East. With the workplace drug testing market in Saudi Arabia alone projected to reach $64.5 million by 2030, the System is well-positioned to meet the growing demand for accessible, efficient, and reliable drug testing solutions across the Middle East[2]. This update will allow for the smooth integration of fingerprint sweat-based testing technology into existing safety protocols, enabling businesses to strengthen workplace safety standards.

“Expanding language support is a crucial step in ensuring our expanded global reach and accessibility of our solution to organizations worldwide,” said Harry Simeonidis, President & CEO of Intelligent Bio Solutions Inc. “Arabic was a logical choice for the second language integrated into our system, given its wide use across the globe. Adding Arabic to our system strengthens our capabilities and presence in the Middle East and will provide more businesses with an intuitive and reliable drug testing solution.”

The integration of Arabic language marks a key milestone in the Company’s broader international growth strategy, reinforcing its footprint in key markets. The enhancement aligns with the Company’s plans to scale operations across North and South America, Europe, Asia Pacific and the Middle East, expanding on its existing presence in 19 countries. This update builds on the Company’s strategic milestones, including its recent FDA 510(k) submission in December 2024 and planned entry into the multi-billion dollar U.S. market in 2025.

References

[1] United Nations 2024. World Arabic Language Day, 18 December. Available at: https://www.un.org/en/observances/arabiclanguageday/

[2] Grand View Research, 2024. Saudi Arabia Employer And Workplace Drug Testing Market Size & Outlook Available at: https://www.grandviewresearch.com/horizon/outlook/employer-and-workplace-drug-testing-market/saudi-arabia/

Princebuild, a leading construction firm with operations across seven sites and six divisions, has adopted the Intelligent Fingerprinting Drug Testing System to strengthen its workplace safety program. The company has transitioned from saliva testing to fingerprint-based screening to introduce a more efficient, in-house solution that supports both operational needs and employee dignity.

A Safer, More Efficient Approach

Headquartered in Peterborough, Cambridgeshire, Princebuild employs the fingerprint system to enhance safety and compliance across its workforce. The simple, quick, and hygienic process enables the HR team to carry out testing on site, providing rapid results with a shorter detection window. This focus ensures employees are fit for duty at the time of testing, without intruding on their personal lifestyles.

Cheryl Browne, Human Resources Support Manager at Princebuild, explained:

“By adopting the fingerprint system, we’ve transformed our approach to workplace testing. We wanted a method that ensures safety without feeling like we are policing lifestyles. The simplicity and efficiency of this solution align perfectly with our company values.”

Widely Adopted in Construction

Princebuild joins a growing list of construction companies using fingerprint testing, including Mount Anvil, Hayfield Homes, Stonbury, MBP Structures, and PJ Hegarty & Sons U.K. Ltd. These organizations use the system as part of their health and safety strategies to deter substance misuse and maintain safe, productive sites.

About the Technology

The Intelligent Fingerprinting Drug Screening System collects fingerprint sweat from all ten fingers in under a minute using a tamper-evident cartridge. Results are displayed in less than ten minutes via a portable analysis unit. The system screens for multiple substances simultaneously, including opiates, cocaine, methamphetamine, and cannabis.

With more than 400 customers across 19 countries, Intelligent Fingerprinting is supporting safety-critical industries such as construction, mining, manufacturing, transport, drug treatment, law enforcement, and forensics.

About Princebuild

Princebuild Limited has cared for, maintained, and built properties since 1971. The company specializes in delivering diverse construction services through six key divisions: construction, small works, insurance, maintenance, building services, and commercial interiors. Over the years, Princebuild has expanded its operations to serve the entire East of England and provides national coverage for larger projects.

We are thrilled to announce that GPS Marine, one of the UK’s leading providers of marine and inland waterway services, has officially adopted Intelligent Fingerprinting’s advanced drug testing system as part of their ongoing efforts to enhance workplace safety. This exciting partnership reflects their unwavering dedication to ensuring the health and safety of their workforce while maintaining seamless and efficient operations in some of the UK’s most safety-critical environments.

About GPS Marine

For over 50 years, GPS Marine has been an indispensable part of the UK’s maritime infrastructure. Specialising in marine construction, logistics, and dredging, the company plays a crucial role in keeping the UK’s waterways navigable and operational. From large-scale dredging projects along the Thames to facilitating the transportation of heavy materials, GPS Marine’s work is both vast and varied, but always held to the highest standards of safety and precision.

Their ability to manage complex, high-risk projects with efficiency and care has made them a trusted name in the maritime sector. Safety has always been at the heart of GPS Marine’s operations, and their partnership with Intelligent Fingerprinting further solidifies their commitment to protecting their workforce while meeting stringent regulatory requirements.

Enhancing Safety and Efficiency with Intelligent Fingerprinting

Working in demanding environments like those managed by GPS Marine, ensuring that all employees are fit for duty is absolutely essential. Safety and reliability are non-negotiable, especially in industries where the consequences of impairment could be catastrophic. Intelligent Fingerprinting’s revolutionary drug screening system offers GPS Marine the perfect solution—one that aligns with their high standards for safety without disrupting their day-to-day activities.

Our drug testing system offers a non-invasive, quick, and hygienic way to detect recent drug use via fingerprint sweat analysis. With results available in just 10 minutes, GPS Marine can make real-time safety decisions, reducing the risk of incidents and maintaining productivity without unnecessary downtime.

Michele Steadman, Compliance and HR Manager at GPS Marine, praised the technology’s impact:

“The introduction of Intelligent Fingerprinting’s drug testing system ensures that we can uphold our commitment to workplace safety while streamlining our processes. The non-intrusive nature of the system, combined with its speed and reliability, makes it a vital addition to our health and safety toolkit. Our team’s safety is our top priority, and this partnership allows us to ensure a safer, more secure working environment without interrupting our workflow.”

For GPS Marine, finding a solution that not only improves safety but also integrates seamlessly into their complex, large-scale operations was critical. Traditional drug testing methods can be time-consuming and disruptive, slowing down critical projects. Intelligent Fingerprinting’s system, however, enables them to conduct tests rapidly, on-site, and without the need for invasive procedures.

John Spencer, Managing Director at GPS Marine, shared his enthusiasm for the new partnership:

“At GPS Marine, keeping our team safe is always our number one priority. But we also need to keep our operations running smoothly, and Intelligent Fingerprinting’s system lets us do just that. It’s incredibly easy to use, and the fact that we can get accurate results in just minutes means there’s no downtime or disruption to our work. This technology is a game-changer for us, and we’re excited to have it as part of our safety procedures.”

This partnership is a testament to GPS Marine’s proactive approach to workplace safety, always looking for innovative ways to protect their team while meeting the growing demands of their industry. By incorporating the Intelligent Fingerprinting system into their safety protocols, GPS Marine is leading by example in setting new standards for how safety-critical industries should approach drug screening.

Interested in enhancing your workplace safety protocols?

Book a free demo today to see how Intelligent Fingerprinting’s drug screening system can benefit your business, or contact us for a consultation and to learn more.

Recent advancements in drug screening technology have been propelled by a groundbreaking study from King’s College London. The research, led by Caroline Pollard and Kim Wolff at Kings College London (KCL), explores usage of the Ridgeway tool from Intelligent Fingerprinting to measure sweat deposition in latent fingerprints (LFPs). This study, published in Forensic Science International, sheds light on a novel application of refractive index (RI) technology, paving the way for more accurate and non-invasive drug testing methods. 

Summary of Research

The Ridgeway tool, developed by Paul Wilson, Head of Special Projects at Intelligent Fingerprinting, and Benjamin Gordon of Gordon Design Consultants, utilises a unique method to measure the refractive index of LFPs, allowing for precise quantification of sweat deposited at the time of fingerprint collection. The study found a strong correlation (r = 0.868) between the Ridgeway score (Rs) and the actual mass of the sweat, demonstrating the tool’s effectiveness. By controlling variables like deposition pressure and surface, the researchers were able to consistently collect comparable fingerprint samples, showing no significant difference between the left and right index fingers. 

What It Means in Common Terms

The Ridgeway tool works like a high-tech set of scales that can “see” how much sweat is present in a fingerprint on a glass surface. This is important because sweat contains small amounts of substances, including drugs, that a person might have ingested. By accurately measuring the amount of sweat, the Ridgeway uniquely enables more precise reporting of drugs present because the size of the fingerprint sample i.e. the size of the person’s fingertips can be considered. Fingerprint drug testing is much simpler and less invasive than traditional drug tests like blood or urine tests. It only requires a person to press their finger on a special slide, and the tool does the rest. 

The study also showed that the Ridgeway could distinguish between different types of sweat left behind in fingerprints. For instance, it could tell if the sweat was from natural bodily processes or if it had been contaminated by touching things like hair or food. This differentiation is crucial for ensuring the accuracy of drug tests, as it helps avoid false positives caused by external contamination. 

Implications and Benefits

This ability to measure sweat deposition accurately offers numerous benefits for drug screening. Traditional methods often require more invasive procedures, but this allows for quick and non-invasive testing. It’s particularly useful in situations where privacy and hygiene are priorities, such as in workplaces or law enforcement settings. Moreover, the tool’s precision in differentiating between sweat types means it can reliably indicate whether drugs were ingested, as opposed to merely coming into contact with a contaminated surface. 

The findings from this study highlight the potential of the Intelligent Fingerprinting method in transforming drug screening processes and cutting-edge science being developed to support the technology. Intelligent Fingerprinting’s platform offers a promising alternative to traditional methods, providing accurate, quick, and dignified testing. As this technology continues to develop, it is setting new standards for fingerprint analysis in forensic science and beyond, making drug testing more accessible and less intrusive.